Xinnaoxuemianning Combined with Statins on Carotid Atherosclerotic Plaque in Patients with Cerebral Infarction
10.3969/j.issn.1005-1678.2017.09.024
- VernacularTitle:中药心脑血脉宁联合他汀类药物对脑梗死患者颈动脉粥样硬化斑块的影响
- Author:
Wei SHEN
;
Dong LIN
- Keywords:
Xinnaoxuemianning;
statins;
cerebral infarction;
carotid atherosclerotic plaque
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(9):65-66,69
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the effects of Xinnaoxuemianning combined with statins on carotid atherosclerotic plaque in patients with cerebral infarction. Methods 180 cerebral infarction patients were divided into the observation group (90cases) and the control group (90cases) by random number table method. The control group was given atorvastatin calcium tablets and the observation group was given additionally Xinnaoxuemianning. The changes and prognosis of carotid atherosclerotic plaques were evaluated before and after treatment, and the incidence of adverse reactions was counted. Results There were no differences in the carotid atherosclerotic plaque, TCM syndrome score and neurological deficit severity between the two groups before treatment. After treatment, the above indexes were significantly improved, and the increasing degree of the observation group was better than that of the control group. The incidence rate of adverse reactions was lower in the observation group than that in the control group (5.56％ vs.13.33％) (P<0.05). Conclusion Xinnaoxuemianning can reduce the carotid atherosclerotic plaque area and correct the unstable plaques in patients with cerebral infarction.
